409
Participants
Start Date
March 1, 2003
Primary Completion Date
February 1, 2004
Study Completion Date
February 12, 2004
Hib-MenCY-TT vaccine (MenHibrix)
Three doses were administered intramuscularly (IM) in left thigh at Months 0,2 and 4 respectively
Meningitec®
Three doses were administered IM in right lower thigh at Months 0,2 and 4.
ActHIB®
Three doses were administered IM in left thigh at Months 0,2 and 4.
Infanrix® Penta
Three doses were administered IM in right upper thigh at Months 0,2 and 4 respectively.
Prevenar®
Three doses were administered IM in right lower thigh at Months 0,2 and 4 respectively.
Mencevax® ACWY
One fifth of one dose was administered IM in deltoid region of right arm at Month 10 as booster.
PRP (Polyribosyl Ribitol Phosphate)
One dose was administered IM in deltoid region of left arm at Month 10 as booster.
GSK Investigational Site, Carlton
GSK Investigational Site, North Adelaide
GSK Investigational Site, Subiaco
Lead Sponsor
GlaxoSmithKline
INDUSTRY